Patents by Inventor Rebeca Martin Rosique

Rebeca Martin Rosique has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11717543
    Abstract: The present invention relates to a bacterial strain of the Faecalibacterium prausnitzii species selected from a bacterial strain belonging to one of the phylogroups I, II and III, for use in the treatment and/or prevention of visceral abdominal pain in an individual. The present invention also concerns compositions comprising said bacterial strains as well as specific strains as such.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: August 8, 2023
    Assignees: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, ECOLE D'INGENIEURS DE PURPAN
    Inventors: Philippe Langella, Sylvie Miquel, Rebeca Martin Rosique, Luis Bermudez Humaran, Muriel Thomas, Harry Sokol, Frédéric Carvalho, Vassilia Theodorou
  • Publication number: 20230167401
    Abstract: The invention relates to a bacterium of the Christensenellaceae family, in particular of the genus Christensenella, or a composition containing same for use in the prevention and/or treatment of chronic inflammatory diseases and/or cancers in humans or animals.
    Type: Application
    Filed: March 11, 2020
    Publication date: June 1, 2023
    Inventors: Georges RAWADI, Sandrine Paule CLAUS, Laure RINALDI, Frédéric ELUSTONDO, Marion Sophie, Madeleine SOTO, Katy Nicole LECORF, Camille Muriel, Dominique, Mathilde KROPP, Philippe LANGELLA, Rebeca MARTIN ROSIQUE, Patrizia BRIGIDI
  • Publication number: 20230036163
    Abstract: The present invention relates to an association of a bacterial strain of the species Faecalibacterium prausnitzii deposited with the CNCM under accession number CNCM I-4573 with mesalamine, or a derivative thereof, and in particular to the use of this association in the treatment and/or prevention of an inflammatory gastrointestinal disease in an individual.
    Type: Application
    Filed: December 17, 2020
    Publication date: February 2, 2023
    Inventors: Christel ROUSSEAUX, Harry SOKOL, Pauline RUFFIE, Jean-Marc CHANTEL, Florian CHAIN, Philippe LANGELLA, Rebeca MARTIN-ROSIQUE
  • Publication number: 20220339207
    Abstract: The present invention relates to a composition for use thereof in the treatment and/or prevention of an inflammatory bowel disease in an individual, the composition comprising, in a physiologically acceptable medium, at least (I) (a) a first bacterial strain of the Faecalibacterium prausnitzii species, and/or (b) a culture supernatant of a first bacterial strain of the Faecalibacterium prausnitzii species; and (II) (a) a second bacterial strain chosen from the group consisting of Christensenella minuta and Christensenella timonensis, and mixtures thereof, and/or (b) a culture supernatant of a second bacterial strain chosen from the group consisting of Christensenella minuta and Christensenella timonensis, and mixtures thereof.
    Type: Application
    Filed: July 23, 2020
    Publication date: October 27, 2022
    Inventors: Philippe LANGELLA, Patrizia BRIGIDI, Rebeca MARTIN ROSIQUE
  • Patent number: 11207358
    Abstract: The present invention relates to a composition comprising a given Lactobacillus rhamnosus strain and a given Lactobacillus paracasei strain wherein the ratio of the given Lactobacillus rhamnosus strain to the given Lactobacillus paracasei strain (LR?:LP?) is higher or equal to 8:1 and to methods thereof.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: December 28, 2021
    Assignee: COMPAGNIE GERVAIS DANONE
    Inventors: Tamara Smokvina, Rebeca Martin Rosique, Philippe Langella
  • Patent number: 10918678
    Abstract: The invention relates to a bacterial strain of species Faecalibacterium prausnitzii deposited at the CNCM under access number CNCM I-4573, for use in the treatment and/or prevention of an inflammatory gastrointestinal illness in an individual.
    Type: Grant
    Filed: January 23, 2017
    Date of Patent: February 16, 2021
    Assignees: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA), SORBONNE UNIVERSITE, ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
    Inventors: Philippe Langella, Rebeca Martin Rosique, Luis Bermudez Humaran, Florian Chain, Harry Sokol
  • Publication number: 20200316138
    Abstract: The present invention relates to a bacterial strain of the Faecalibacterium prausnitzii species selected from a bacterial strain belonging to one of the phylogroups I, II and III, for use in the treatment and/or prevention of visceral abdominal pain in an individual. The present invention also concerns compositions comprising said bacterial strains as well as specific strains as such.
    Type: Application
    Filed: June 22, 2020
    Publication date: October 8, 2020
    Inventors: Philippe LANGELLA, Sylvie MIQUEL, Rebeca MARTIN ROSIQUE, Luis BERMUDEZ HUMARAN, Muriel THOMAS, Harry SOKOL, Frédéric CARVALHO, Vassilia THEODOROU
  • Publication number: 20200078420
    Abstract: The present invention relates to a composition comprising a given Lactobacillus rhamnosus strain and a given Lactobacillus paracasei strain wherein the ratio of said given Lactobacillus rhamnosus strain to said given Lactobacillus paracasei strain (LR?:LP?) is higher or equal to 8:1.
    Type: Application
    Filed: December 16, 2016
    Publication date: March 12, 2020
    Inventors: Tamara SMOKVINA, Rebeca MARTIN ROSIQUE, Philippe LANGELLA
  • Publication number: 20190381115
    Abstract: The present invention relates to a bacterial strain of the Faecalibacterium prausnitzii species selected from a bacterial strain belonging to one of the phylogroups I, II and III, for use in the treatment and/or prevention of visceral abdominal pain in an individual. The present invention also concerns compositions comprising said bacterial strains as well as specific strains as such.
    Type: Application
    Filed: November 13, 2015
    Publication date: December 19, 2019
    Applicants: INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (APHP), ECOLE D'INGENIEURS DE PURPAN
    Inventors: Philippe LANGELLA, Sylvie MIQUEL, Rebeca MARTIN ROSIQUE, Luis BERMUDEZ HUMARAN, Muriel THOMAS, Harry SOKOL, Frédéric CARVALHO, Vassilia THEODOROU
  • Publication number: 20190030089
    Abstract: The invention relates to a bacterial strain of species Faecalibacterium prausnitzii deposited at the CNCM under access number CNCM I-4573, for use in the treatment and/or prevention of an inflammatory gastrointestinal illness in an individual.
    Type: Application
    Filed: January 23, 2017
    Publication date: January 31, 2019
    Applicants: Institut National De La Recherche Agronomique (INRA), Sorbonne Universite, Assistance Publique - Hopitaux de Paris
    Inventors: Philippe Langella, Rebeca Martin Rosique, Luis Bermudez Humaran, Florian Chain, Harry Sokol